Fig. 2From: Therapeutic activity of sarpogrelate and dopamine D2 receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetesEffect of the tested drugs on the percentage of myocardial infarct size in alloxan-induced diabetic rats. Values shown are mean ± SEM; n = 6 rats per group. # P < 0.05, significantly different from the diabetic control group. (a) P < 0.05, significantly different from the diabetic group treated with bromocriptine. (b) P < 0.05, significantly different from the diabetic group treated with cabergolineBack to article page